Evaluation of a dominant-negative recombinant herpes simplex virus (HSV) type 1 as a vaccine against genital herpes in mice und guinea pigs
Autor(en): | Brans, R. | Stichwörter: | Dermatology; DISEASE; Genital herpes; Glycoprotein D; GLYCOPROTEIN-D; Herpes simplex virus; HSV; INFECTION; PREVENTION; Replication defective | Erscheinungsdatum: | 2010 | Herausgeber: | SPRINGER | Journal: | HAUTARZT | Volumen: | 61 | Ausgabe: | 12 | Startseite: | 1073 | Seitenende: | 1077 | Zusammenfassung: | Genital herpes caused by herpes simplex virus (HSV) is one of the most common sexually transmitted diseases worldwide. Currently, no safe and effective vaccine against HSV is available. CJ9-gD is a completely replication-defective HSV-1 recombinant which inhibits replication of wild-type HSV-1/-2 in co-infected cells (dominant-negative effect). Moreover, it expresses high levels of HSV-1 major antigen glycoprotein D (gD). Immunization with CJ9-gD induces strong and long-lasting humoral and Th1-like cellular immune responses against both HSV-1 and HSV-2 in mice protecting immunized animals significantly against genital challenge with HSV-1 or HSV-2. Guinea pigs immunized with CJ9-gD were significantly protected against primary and recurrent HSV-2 genital disease and latent infection. |
ISSN: | 00178470 | DOI: | 10.1007/s00105-010-2075-8 |
Zur Langanzeige
Seitenaufrufe
2
Letzte Woche
1
1
Letzter Monat
1
1
geprüft am 01.06.2024